Skip to content

Medical-device intelligence

QOF: Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents

FDA product code QOF: Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
QOF
FDA device name
Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents
Device class
2
Regulation number
866.3981
Medical specialty
Microbiology
Review panel
MI

FDA definition

A device to detect and identify nucleic acid targets in respiratory specimens from microbial agents that cause the SARS-CoV-2 respiratory infection and other microbial agents when in a multi-target test is an in vitro diagnostic device intended for the detection and identification of SARS-CoV-2 and other microbial agents when in a multi-target test in human clinical respiratory specimens from patients suspected of respiratory infection who are at risk for exposure or who may have been exposed to these agents. The device is intended to aid in the diagnosis of respiratory infection in conjunction with other clinical, epidemiologic, and laboratory data or other risk factors.
Explore microbiology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

38 clearance records and 9 recall records in the covered releases, across 19 source company names and 1 product codes. Dated history runs from Feb 1, 2023 to Oct 30, 2026.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202511
November 202500
December 202510
January 202600
February 202610
March 202610
April 202601
May 202600
June 202611
July 202600
August 202600
September 202630
October 202630

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

47 matching records
Device / recordCompany in FDA recordSourceSource date
cobas eplex respiratory pathogen panel 3K262938 · QOFGenMark Diagnostics, Inc.510(k)Oct 30, 2026FDA decision date
Xpert Xpress CoV-2/Flu plusK263333 · QOFCepheid®510(k)Oct 22, 2026FDA decision date
Xpert Xpress CoV-2/Flu plusK263120 · QOFCepheid®510(k)Oct 2, 2026FDA decision date
Xpert Respiratory PanelK261336 · QOFCepheid510(k)Sep 25, 2026FDA decision date
BIOFIRE Respiratory Panel 2.1 (RP2.1)K263054 · QOFBiofire Diagnostics510(k)Sep 22, 2026FDA decision date
FINDER Flu A&B/SARS-CoV-2 TestK261837 · QOFBaebies, Inc.510(k)Sep 11, 2026FDA decision date
BIOFIRE Respiratory Panel 2.1 (RP2.1) REF 423742 UDI code: 00815381020529 PCR-based multiplexed nucleic acid test, in vitro diagnosticZ-2936-2026 · QOFBioFire Diagnostics, LLCRecallAug 12, 2026FDA classification date
Fast PCR Mini Respiratory PanelK252932 · QOFAutonomous Medical Devices Incorporated510(k)Jun 12, 2026FDA decision date
Biofire Spotfire Respiratory/Sore Throat Panel REF: 423485Z-2081-2026 · QOFBioFire Diagnostics, LLCRecallMay 6, 2026FDA classification date
FINDER Flu A&B/SARS-CoV-2 TestK252269 · QOFBaebies, Inc.510(k)Mar 30, 2026FDA decision date
VELO Respiratory TestK251742 · QOFLex Diagnostics Limited510(k)Feb 13, 2026FDA decision date
LIAISON NES FLU A/B, RSV & COVID-19K251978 · QOFDiasorin Molecular, LLC510(k)Dec 23, 2025FDA decision date
BioFire Respiratory Panel 2.1, IVD, REF: 423742 (30 test kit)Z-0602-2026 · QOFBioFire Diagnostics, LLCRecallNov 26, 2025FDA classification date
Simplexa™ COVID-19/ Flu A/B & RSV Direct (MOL4450); Simplexa™ COVID-19/ Flu A/B & RSV Positive Control Pack (MOL4460)K252387 · QOFDiasorin Molecular, LLC510(k)Oct 30, 2025FDA decision date
QIAstat-Dx Respiratory Panel Plus; QIAstat-Dx Respiratory Panel MiniK250080 · QOFQIAGEN GmbH510(k)Aug 27, 2025FDA decision date
BIOFIRE SPOTFIRE Respiratory/Sore Throat Panel MiniK243544 · QOFBiofire Diagnostics, LLC510(k)Aug 14, 2025FDA decision date
DASH SARS-CoV-2 & Flu A/B Test Model/Catalog Number: SG-0006 combination COVID-19 and Flu test. Each DASH SARS-CoV-2 & Flu A/B Test is indi…Z-2274-2025 · QOFNuclein LLCRecallAug 6, 2025FDA classification date
cobas Respiratory 4-flex for use on the cobas 5800/6800/8800 SystemsK243455 · QOFRoche Molecular Systems, Inc.510(k)Jul 31, 2025FDA decision date
Xpert Xpress CoV-2/Flu/RSV plusK250995 · QOFCepheid®510(k)May 1, 2025FDA decision date
Xpert Xpress CoV-2/Flu/RSV plusK250996 · QOFCepheid®510(k)May 1, 2025FDA decision date
cobas liat SARS-CoV-2 & Influenza A/B v2 nucleic acid testK243400 · QOFRoche Molecular Systems, Inc.510(k)Apr 25, 2025FDA decision date
cobas liat SARS-CoV-2, Influenza A/B & RSV nucleic acid testK243406 · QOFRoche Molecular Systems, Inc.510(k)Apr 25, 2025FDA decision date
Brand Name: QIAstat-Dx Product Name: QIAstat-Dx Respiratory Panel Plus Reference Number (REF): 691224 Software Version: n/a Component: n/aZ-1504-2025 · QOFQiagen Sciences LLCRecallMar 31, 2025FDA classification date
Visby Medical Respiratory Health TestK242526 · QOFVisby Medical, Inc.510(k)Feb 19, 2025FDA decision date
Alinity m Resp-4-PlexK241573 · QOFAbbott Molecular, Inc.510(k)Feb 14, 2025FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗